NCT06047886View on ClinicalTrials.gov

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 22, 2025

Primary Completion Date

October 31, 2029

Study Completion Date

December 31, 2029

Conditions
AMLALLLymphoid MalignanciesMyelodysplastic SyndromesCMLPrimary Myelofibrosis
Interventions
DRUG

Infusion of CD34 selected hematopoietic stem cells

CD34 stem cell isolation and infusion to reduce alloreactive complication of stem cell infusion

Trial Locations (1)

35294-3300

RECRUITING

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER